Cargando…

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a progressive, life-threatening lung disease with increasing prevalence and incidence worldwide. Increasing evidence suggests that lung microbiomes might play a physiological role in acute exacerbations of COPD. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chia-Yu, Li, Shiao-Wen, Chin, Chia-Yin, Hsu, Chia-Wei, Lee, Chi-Ching, Yeh, Yuan-Ming, Wu, Kuo-An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988976/ https://www.ncbi.nlm.nih.gov/pubmed/33757530 http://dx.doi.org/10.1186/s12967-021-02788-4

Ejemplares similares

Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease
por: Liu, Hai-Yue, et al.
Publicado: (2017)

Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease
por: Qi, Yu-Jing, et al.
Publicado: (2020)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)

Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease
por: Manjhi, Rekha, et al.
Publicado: (2022)

Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability
por: Dang, Xiaomin, et al.
Publicado: (2022)

Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease
por: Diao, Wenqi, et al.
Publicado: (2018)

Sputum Inflammometry to Manage Chronic Obstructive Pulmonary Disease Exacerbations: Beyond Guidelines
por: Venegas, Carmen, et al.
Publicado: (2020)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Su, Linfan, et al.
Publicado: (2022)

Acute exacerbation of chronic obstructive pulmonary disease in United States emergency departments, 2010–2018
por: Liew, Chiat Qiao, et al.
Publicado: (2023)

Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation
por: Barta, Imre, et al.
Publicado: (2022)

Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Gao, Peng, et al.
Publicado: (2013)

Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices
por: Su, Linfan, et al.
Publicado: (2022)

Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2015)

Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints
por: Malvisi, Lucio, et al.
Publicado: (2021)

Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018)

Could the Sputum Microbiota Be a Biomarker That Predicts Mortality after Acute Exacerbations of Chronic Obstructive Pulmonary Disease?
por: Tsay, Jun-Chieh J., et al.
Publicado: (2019)

Sputum myeloperoxidase in chronic obstructive pulmonary disease
por: Zhu, Alling, et al.
Publicado: (2014)

Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus‐predominant subgroup
por: Diver, Sarah, et al.
Publicado: (2019)

Eosinophil values in exacerbation and stable chronic obstructive pulmonary disease and its relationship to maintenance therapy in stable chronic obstructive pulmonary disease patients
por: Fachri, Muhammad, et al.
Publicado: (2023)

The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease
por: Liu, Xuanqi, et al.
Publicado: (2020)

Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study
por: Mohan, Sindu, et al.
Publicado: (2017)

Diaphragm Ultrasound is an Imaging Biomarker that Distinguishes Exacerbation Status from Stable Chronic Obstructive Pulmonary Disease
por: An, Tai Joon, et al.
Publicado: (2022)

The relationship of depression in asthma–chronic obstructive pulmonary disease overlap syndrome
por: Yeh, Jun-Jun, et al.
Publicado: (2017)

Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection
por: Kayongo, Alex, et al.
Publicado: (2023)

Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
por: Ditz, B, et al.
Publicado: (2021)

Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism
por: Yeh, Jun-Jun, et al.
Publicado: (2016)

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
por: Wedzicha, Jadwiga A, et al.
Publicado: (2013)

Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease
por: Bouhuis, Dennis, et al.
Publicado: (2023)

Acute Exacerbation of a Chronic Obstructive Pulmonary Disease Prediction System Using Wearable Device Data, Machine Learning, and Deep Learning: Development and Cohort Study
por: Wu, Chia-Tung, et al.
Publicado: (2021)

Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations
por: Chin, Melanie, et al.
Publicado: (2015)

Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease
por: Qiu, Weiliang, et al.
Publicado: (2011)

Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease
por: Yang, Chengyu, et al.
Publicado: (2023)

Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
por: Haldar, Koirobi, et al.
Publicado: (2017)

The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD)
por: Li, Chin-Ling, et al.
Publicado: (2022)

Serum Levels of Gamma-Glutamyltransferase During Stable and Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Sun, Desheng, et al.
Publicado: (2020)

Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis
por: Byun, Min Kwang, et al.
Publicado: (2017)

Association of meteorological factors and air NO(2) and O(3) concentrations with acute exacerbation of elderly chronic obstructive pulmonary disease
por: Lin, Ming-Tai, et al.
Publicado: (2018)

Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?
por: Uslu, Berat, et al.
Publicado: (2022)

Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury
por: Chang, Kan-Hsun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nebpufjs49ddruhjar1gcnioq2